Contemporary Pediatrics eConsult

September 13, 2012

Web Version  |  Unsubscribe  |  Digital Edition  |   Share with a colleague

Facebook Like   Twitter Tweet

TODAY'S HEADLINES

Childhood vaccine coverage misses target

The Centers for Disease Control and Prevention says that when it comes to measles, mumps, and rubella and varicella vaccination of children entering school, coverage is still not quite where it needs to be. Find out which states are the leaders and which states lag behind. » More

Share »facebook twitter LinkedIn Google+

Brain impairments linked with metabolic syndrome

Adolescents with metabolic syndrome have significantly lower cognitive performance and reductions in brain structural integrity, New York University researchers have found. Can these impairments affect a teenager's academic or future professional potential? » More

Share »facebook twitter LinkedIn Google+

TAKE OUR SURVEY

The rule in most school districts is, "No shots, no school," but some districts allow a parent to simply sign a form to be exempted for purely personal beliefs. Do you think there should be legislation in place that prohibits schools from allowing anyone to opt out of vaccinations without a valid medical reason?

- Yes
- No
- I don't know

Click here to let us know.

Last month we asked if you had to mince words when talking to parents about their overweight children. Click here to find out the results of this survey.

Child mental health care linked to parent approval

Children are more likely to remain in treatment for mental health issues if their parents consider the therapy to be beneficial, a recent study reports. What are the implications for child mental health care? » More

Share »facebook twitter LinkedIn Google+

Don't give sildenafil to children, FDA warns

Children aged between 1 and 17 years should not take sildenafil for pulmonary artery hypertension, a MedWatch safety communication from the US Food and Drug Administration (FDA) warns. » More

Share »facebook twitter LinkedIn Google+

FDA approves pediatric dosage of everolimus

The US Food and Drug Administration (FDA) has approved a new pediatric dosage form of everolimus for the treatment of subependymal giant cell astrocytoma (SEGA), a rare brain tumor in children. » More

Share »facebook twitter LinkedIn Google+
 
 

Subscribe Now!

You must click here to continue receiving the Contemporary Pediatrics eConsult

Advertisement

Related Articles

2012 a record year for whooping cough

Serum uric acid predicts metabolic syndrome

FDA vouchers expanded for pediatric drugs

Imported measles linked to US outbreaks

Increase fiber, reduce fat in adolescents

Viagra for babies?

New Job Opportunities

DE • F Bacchus MD

MI • Company Confidential

We want your feedback

Do you have ideas for new departments? Feature articles? News or Commentary? If you have suggestions for making Contemporary Pediatrics eConsult or print edition better, we'd like to know. Send comments and ideas to kmethod@advanstar.com.

 
Powered by Modern Medicine Advanstar Medical Communications Group